PFSA (Profusa Inc) ערך שוק

The Profusa Inc (PFSA) price chart is based on the ownership of its own US-based biosensor laboratories, while electronics assembly is delegated to external contractors. The company is developing subcutaneous sensors for diabetes monitoring and wound healing, with a market capitalization of 0.00. However, prolonged regulatory reviews and a shortage of funds for clinical trials create serious financial threats.

Profusa Inc (PFSA) focuses on developing bio-integrable sensors, which require extensive R&D expenditures amid a shortage of operating revenue. Total shareholder value, calculated as the product of the market price and the number of shares, digitizes the current valuation of this potential. This metric measures the issuer's aggregate capital, determining its investment attractiveness and liquidity. Sharp fluctuations in value could lead to an asset freeze. Analysis based on the company's current market capitalization allows for the monitoring of critical safety thresholds.